The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

According to ratings by the Scientific Registry of Transplant Recipients, released Tuesday evening, choosing UF Health for a liver transplant over any other program in the country gives patients the ...

The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...

The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...

The FDA approves SIR-Spheres Y-90 microspheres for treating unresectable hepatocellular carcinoma, showcasing impressive ...

The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...

Stimuli-triggered nanoplatforms have become attractive candidates for combined strategies for advanced liver cancer treatment. In this study, we designed a light-responsive nanoplatform with folic ...